ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 73.70
-1.70 (-2.25%)
May 29, 2026, 1:55 PM CST
ACRO Biomedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -82.66 | -62.09 | -41.42 | -60.88 | -50.78 |
Depreciation & Amortization | 15.72 | 11.78 | 9.71 | 8.24 | 9.48 |
Other Amortization | 0.82 | 1.7 | 1.27 | 0.98 | 0.03 |
Loss (Gain) From Sale of Assets | 0.02 | 0.15 | - | - | - |
Loss (Gain) From Sale of Investments | -1.4 | 1.33 | -2.77 | -0.5 | -1.81 |
Stock-Based Compensation | 12.11 | 1.39 | - | 0.74 | 1.39 |
Provision & Write-off of Bad Debts | -0.67 | -1.85 | 3.55 | - | 0 |
Other Operating Activities | 5.95 | 0.35 | -20.46 | 4 | 0.53 |
Change in Accounts Receivable | 5.16 | -2.56 | 2.32 | -5.01 | -0.46 |
Change in Inventory | -8.12 | -1.72 | 2.9 | -1.96 | -1.69 |
Change in Accounts Payable | 0.28 | 0.36 | 0.09 | 0.24 | -0.13 |
Change in Unearned Revenue | -1.61 | 2.31 | 0.12 | -0.23 | -2.86 |
Change in Other Net Operating Assets | 5.38 | 5.47 | -3.58 | 9.24 | -1.52 |
Operating Cash Flow | -49.01 | -43.38 | -48.27 | -45.15 | -47.83 |
Capital Expenditures | -12.82 | -30.55 | -21 | -2.74 | -0.37 |
Sale of Property, Plant & Equipment | - | 0.02 | - | - | - |
Sale (Purchase) of Intangibles | -1.14 | -0.08 | -1.46 | -1.7 | -2.93 |
Investment in Securities | 100 | -272.13 | -10.6 | -4.1 | 40.21 |
Other Investing Activities | -1.64 | -1.92 | -0.54 | -2.01 | -0.05 |
Investing Cash Flow | 84.41 | -304.67 | -33.59 | -10.54 | 36.86 |
Long-Term Debt Repaid | -5.26 | -5.25 | -4.72 | -3.45 | -3.42 |
Net Debt Issued (Repaid) | -5.26 | -5.25 | -4.72 | -3.45 | -3.42 |
Issuance of Common Stock | 550.02 | - | 350 | 307.85 | - |
Financing Cash Flow | 544.76 | -5.25 | 345.28 | 304.4 | -3.42 |
Foreign Exchange Rate Adjustments | -1.23 | 0.89 | -1.1 | 0.88 | 1 |
Net Cash Flow | 578.93 | -352.41 | 262.31 | 249.58 | -13.4 |
Free Cash Flow | -61.83 | -73.93 | -69.27 | -47.89 | -48.2 |
Free Cash Flow Margin | -161.62% | -167.13% | -135.66% | -173.30% | -220.80% |
Free Cash Flow Per Share | -1.01 | -1.21 | -1.31 | -1.01 | -1.36 |
Cash Interest Paid | 0.22 | 0.29 | 0.26 | 0.1 | 0.09 |
Cash Income Tax Paid | 0.17 | 0.27 | 0.17 | 0.06 | - |
Levered Free Cash Flow | -45.84 | -54.55 | -36.11 | -27.51 | -32.07 |
Unlevered Free Cash Flow | -45.7 | -54.37 | -35.95 | -27.45 | -32.02 |
Change in Working Capital | 1.1 | 3.86 | 1.86 | 2.28 | -6.66 |